The programme included these industry experts:
- André Michel Ballester, CEO Sorin Group
- Bruce de la Grange, previously of Plus Orthopedics / Smith & Nephew
- Brian Steer, Executive Chairman of Stanmore Orthopedics and previously of Gyrus Group PLC
Wednesday 3 December 2008
| 4:00 pm | Registration |
| 7:00 pm | Opening Reception |
Thursday 4 December 2008
| 7:30 am | Breakfast |
| 8:30 am | Is there a Funding Gap?—Panel and Debate There are more device companies being launched and more venture dollars available than ever before. However, given the recent turmoil in the financial markets, funding companies all the way through to exit may become harder than ever. In this session, we look at the current financing climate for device start-ups. Prof. Dr. Ulrich Abshagen, Founding Managing Partner, Heidelberg Innovation Tim Haines, Partner, Abingworth Tim Lenihan, CEO, MD Start Berthold Hackl, Invendo Medical Moderator: Antoine Papiernik, Sofinnova |
| 9:45 am | Refreshment Break |
| 10:15 am | Regulatory and Reimbursement Compliance Issues Affecting Global Companies This interactive panel discussion among senior industry regulatory and compliance executives explores the current regulatory and reimbursement compliance challenges facing the device community. It includes case studies of high profile calamities identifying the root causes of concern and subsequent remediation requirements worldwide. Sarah Sorrel, President, MedPass Myriam Desmet, ex-Regulatory Compliance Manager for Kyphon Kathleen Lundberg, Sr VP and CCO Global Compliance, Boston Scientific Christopher L. White, AdvaMed General Counsel, Advanced Medical Technology Association Donna M. Hill, VP, Associate General Counsel, Cardinal Health Medical Products & Technologies Moderator: Brian Riewerts, PricewaterhouseCoopers LLP |
| 11:30 am | Clinical Markets Panels In these sessions, we will explore the technological and commercial opportunities and challenges for three of the device industry’s most important segments: Orthopedics, Cardiovascular, and Neuromodulation. |
| Session 1—Orthopedic Panel and Debate
Jacques Essinger, CEO, Symetis Julian Mackenzie, CEO, SpineVision Steve Foster, VP Spine & Biologics / Navigation, Medtronic John Dougall, ex-VP Strategic Relations of DePuy International (a Johnson & Johnson Company) Moderator: Bruce de la Grange, previously of Plus Orthopedics/Smith & Nephew |
|
| 12:45 pm | Luncheon |
| 1:45 pm | Awardee Spotlight: A conversation with the 2008 Company of the Year Award winner |
| 3:00 pm | Session 2—Neuromodulation Panel and Debate Stephen McCormack, CEO, Intelligent Medical Implants AG Khalid Ishaque, General Manager Neuromodulation Int., Boston Scientific Int. S.A Dr. Alim-Louis Benabid, Chairman of neurosurgery, Joseph Fourier University Paul Pyzowski MBA, CEO and co-founder, Aleva Neurotherapeutics Moderator: Casey McGlynn, Wilson Sonsini Goodrich & Rosati |
| 4:15 pm | Refreshment Break |
| 4:45 pm | Session 3—Cardiology Panel and Debate
Jaques Seguin, Chairman of the Board, CoreValve Gonzague Issenmann, CEO, Stentys Tor Peters, CEO, NOLabs Dr. David Foley, Consultant Cardiologist — Beaumont Hospital Michael Buck, Director of Business Development, Abbott Laboratories Moderator: Steven Levin, Windhover |
| 7:00 pm | Summit Dinner |
Friday 5 December 2008
| 7:30 am | Breakfast |
| 8:30 am | Chinese Panel China with its huge populations and vast resources has long been viewed as a potentially valuable market. In the last couple of years we have seen China really emerge as a land of promise and opportunity. In this panel, we will look at the burgeoning market for medical devices and device start-ups in China. Bill McKeon, CEO, Starbridge Yi Zhang (Michael Zhang), CEO Achieva Medical Ty Hu, President, Innomed Moderator: Antoine Papiernik, Sofinnova |
| 9:30 am | Exit Panel and Industry Overview The success of any device company is measured not just in technological or clinical terms, but in commercial terms as well—i.e., is the company generating an attractive return for its investors? But both public offerings and M&A go through ups-and-downs, making the assessment of the exit opportunity sometimes difficult. This panel will explore the current environment for IPOs and M&A. Eric Baas, Director of Medicine and Technology, Medtronic Rodney Perkins, Chairman, SurgRx Maximilian Reindl, Founder and CEO, WaveLight AG Mark Secrest, Managing Director Investment Banking, Cowen & Co. Moderator: Tracy Lefteroff, PricewaterhouseCoopers LLP |
| 11:00 am | Refreshment Break |
| 11:30 am | VIP Interview with André Michel Ballester, CEO, Sorin Group conducted by David Cassak, Windhover |
| 1:00 pm | Luncheon |
Download 2008 Bohemian Medical Device Summit Agenda